Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Inflammatory Bowel Disease IV: Pharmacological Management
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Kellyn M Moran1, Sarah S Hellems2, Kiraat D Munshi1
1Takeda Pharmaceuticals U.S.A., Inc., Cambridge, MA, USA.
使用精算方法的新风险调整模型可以预测炎症性肠病 (IBD) 的成本. 这些模型是从索赔数据中开发的,它们显示了在管理IBD患者费用的现实实用性.
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
09:44Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
结论: